![](/documents/10803/9944840/parasitic-worms-immune-system-thumbnail.png/66dd05d8-8da9-7b74-4688-6c0483f05434?t=1660227187241)
Parasitic worms reprogram intestinal stem cells to evade the immune system
A new collaboration between immunoparasitologists and stem cell biologists at the RI-MUHC describes...
![](/documents/10803/7796850/dr-bourbeau-study-pollution-thumbnail.jpg/401ed3ea-e169-2fbb-822d-6138b0fed9c1?t=1653576002825)
New study shows associations between air pollution and respiratory health in Canada
RI-MUHC researchers demonstrate that exposure to relatively low levels of air pollution in Canada is associated...
![](/documents/10803/6563050/new-funding-mi4-thumbnail.jpg/69003b04-c3b9-1449-4320-c1f9c9880e40?t=1651067314504)
Five RI-MUHC researchers receive new funding from MI4
Cutting-edge projects in infection and immunity supported in Round 4 of MI4’s Seed Fund Grant program
![](/documents/10803/6376855/tb-covid-battle-thumbnail.jpg/f639731d-0f8f-0b4f-400b-45099e86a925?t=1648128400706)
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
![](/documents/10803/6290859/dr-divangahi-bcg-vaccine-thumbnail.jpg/ae440f7c-986e-d46f-542c-2bdc6cce41bc?t=1646843306571)
BCG vaccine provides protection against influenza virus but not SARS-CoV-2
A new study led by RI-MUHC researchers reveals that the 100-year-old tuberculosis vaccine known as..
![](/documents/10803/6242894/grips-rare-disease-thumbnail.jpg/363ad6ed-ee5b-92de-bf90-af559525585d?t=1645713623380)
Beyond basic research: Coming to grips with a rare disease experience
To honour Rare Disease Day on February 28, an RI-MUHC research trainee shares the perspective he gained as a patient
![](/documents/10803/6254830/dr-petrof-muscular-dystrophy-thumbnail.jpg/711468df-4cbc-9081-85f3-11d97a3c2c22?t=1644946363554)
RI-MUHC team uncovers new mechanism of inflammation in muscular dystrophy
A new study reveals how signals sent from damaged muscles to the bone marrow can induce long-lasting...
![](/documents/10803/6242894/cihr-results-fall-2021-thumbnail.jpg/5f64c182-30b9-7480-b9fb-2d350ec0efb5?t=1644515247006)
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
![](/documents/10803/6094958/three-crc-renewal-thumbnail.jpg/45fc6e52-8fb2-32ef-3d08-4c523f8a7365?t=1643290666070)
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
![](/documents/10803/5130930/dr-bourbeau-phase-three-thumbnail.jpg/23d221d0-3fe2-a426-fe9b-77a28ac18df0?t=1638218924662)
Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started